One of these inhibitory molecules is programmed cell death ligand-1 (PD-L1), which binds to programmed cell death 1 (PD-1) expressed on T cells, B cells, dendritic cells and natural killer T cells, to suppress anti-cancer immunity. This evidence concerns the gene PDCD1 and cancer.